logo

Seagen Inc (SGEN)



Trade SGEN now with
  Date
  Headline
12/8/2020 8:07:47 AM Seagen Announces Presentation Of New Data From TUKYSA At SABCS Symposium
12/7/2020 10:06:16 AM Seagen Reports Multiple ADCETRIS Presentations At the 2020 ASH Annual Meeting
11/17/2020 7:56:26 AM William Blair Reiterates Seattle Genetics Inc. (SGEN) At Outperform
11/9/2020 8:07:15 AM Seagen Presents Immuno-Oncology Data From Broad Portfolio During SITC Virtual Annual Meeting 2020
11/5/2020 8:13:15 AM Seagen Announces Multiple ADCETRIS Presentations At Upcoming ASH Annual Meeting
10/30/2020 10:06:54 AM Stock Alert: Seagen Tumbles 9%
10/29/2020 4:13:12 PM Seagen Q3 EPS $3.50 Vs. Loss $0.55 Year Ago
10/28/2020 8:04:58 AM Seagen Reports Closing Of $1.0 Bln Stock Sale To Merck
10/12/2020 6:51:09 AM Astellas, Seagen Announce Positive Topline Results From Second Cohort Of Patients In Phase 2 Pivotal Trial Of PADCEV
10/8/2020 8:03:51 AM Seattle Genetics, Inc. Changes Corporate Name To Seagen Inc.; Ticker Symbol To Continue Under "SGEN"
9/21/2020 10:26:22 AM Seattle, Genmab Present Data From Tisotumab Vedotin InnovaTV 204 Trial In Recurrent Or Metastatic Cervical Cancer
9/18/2020 6:51:03 AM Seattle Genetics And Astellas Pharma Announce Phase 3 Trial Of PADCEV Meets Primary Endpoint
9/14/2020 6:52:01 AM Seattle Genetics, Merck Announce Strategic Oncology Collaborations; Merck To Buy $1 Bln Equity Stake In Seattle Genetics
8/27/2020 8:13:26 AM Seattle Genetics To Receive Milestone Payment From GlaxoSmithKline Under ADC Collaboration